New USP Standards Guide Prescription Container Labels - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New USP Standards Guide Prescription Container Labels



The US Pharmacopeial Convention (USP) released standards that, for the first time, provide a universal approach to organizing labels for prescription containers dispensed by pharmacists. The new standards aim to eliminate the variability that currently exists between pharmacies across the US and improve patient understanding of medication instructions by giving direction for optimal format, appearance, content, and language.

“Lack of universal standards for labeling on dispensed prescription containers is a root cause for patient misunderstanding, nonadherence, and medication errors,” said Joanne G. Schwartzberg, MD, director of aging and community health for the American Medical Association and a member of the USP Nomenclature, Safety, and Labeling Expert Committee, which was responsible for the new standard, in an Oct. 9, 2012, press release. “With an aging and increasingly diverse population, and people utilizing a growing number of medications, the risks are more pronounced today than ever,” said Schwartzberg. The USP standards will promote patient understanding of medication instructions, she notes.

The standards explain how to create labels that reflect how most patients seek out and understand instructions. The standards include detailed instructions for how to:

  • Emphasize instructions and information important to patients
  • Improve readability
  • Give explicit instructions
  • Include purpose for use
  • Address limited English proficiency
  • Address visual impairment.

The final version of the standard will be published in November 2012, and will incorporate changes based on feedback on the draft version, which was released for public comment in December 2011. The boards of pharmacy in individual states may choose to adopt the standard into their regulations. The National Association of Boards of Pharmacy passed a resolution in May 2012 supporting state boards in requiring a standardized label.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here